Table 4 |
|||||||||
|
SCORE risk at baseline and follow-up |
|||||||||
|
Patients without diabetes1 or MetSyn2 |
Patients with MetSyn2 |
Patients with diabetes1 |
|||||||
|
N |
mean |
± SD |
N |
mean |
± SD |
N |
mean |
± SD |
|
|
|
|||||||||
|
Total |
|||||||||
|
baseline |
225 |
6.4 |
6.0 |
885 |
7.4 |
6.7 |
818 |
19.8 |
14.4 |
|
8 weeks |
139 |
3.5 |
3.1 |
576 |
4.0 |
3.5 |
607 |
11.2 |
8.2 |
|
Difference3 |
138 |
-2.7* |
3.8 |
568 |
-3.2* |
3.6 |
590 |
-8.7* |
8.7 |
|
|
|||||||||
|
Blood pressure alone |
|||||||||
|
baseline |
225 |
6.4 |
6.0 |
885 |
7.4 |
6.7 |
818 |
19.8 |
14.4 |
|
8 weeks |
132 |
6.1 |
5.6 |
557 |
6.8 |
5.9 |
589 |
19.1 |
13.2 |
|
Difference3 |
132 |
-0.4* |
1.2 |
555 |
-0.7* |
1.4 |
578 |
-1.4* |
3.3 |
|
|
|||||||||
|
Risk factors alone |
|||||||||
|
baseline |
225 |
6.4 |
6.0 |
885 |
7.4 |
6.7 |
818 |
19.8 |
14.4 |
|
8 weeks |
221 |
3.9 |
3.4 |
873 |
4.5 |
4.0 |
789 |
12.4 |
8.8 |
|
|
|||||||||
|
Difference3 |
219 |
-2.6* |
3.4 |
862 |
-2.9* |
3.3 |
786 |
-7.6* |
7.7 |
|
|
|||||||||
|
1 diagnosis assigned by physician; 2 defined by the AHA/NHLBI 2004 [17]; 3 difference versus baseline; * p < 0.0001. |
|||||||||
|
Bramlage et al. BMC Cardiovascular Disorders 2008 8:30 doi:10.1186/1471-2261-8-30 |
|||||||||
